Prof Jan Cohen Tervaert (J.W.)

 

Top publications:

Hilhorst M, van Paassen P, Tervaert JW. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol. 2015 ;26(10):2314-27

Lyons PA, Rayner TF, Trivedi S, et al. Genetically distinct subsets within ANCA-associated vasculitis. New Engl J Med 2012; 367: 214-223.

 

Wilde B, Van Paassen P, Witzke O, Cohen Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int. 2011;79:599-612.

 

Jones RB, Cohen Tervaert JW, Hauser T, et al. Rituximab versus cyclophosphamide in ANCA associated renal vasculitis.  New Engl J Med 2010;363:211-220.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Cohen Tervaert JW, et al. A randomised trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.  New Engl J Med  2003;349:36-44.

Stegeman CA, Cohen Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim-sulfamethoxazole (cotrimoxazole) for the prevention of relapses of Wegener’s granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. New Engl J Med. 1996; 335:16-20.

Cohen Tervaert JW, Huitema MG, Hené RJ, Sluiter WJ, The TH, van der Hem GK, Kallenberg CG. Prevention of relapses in Wegener’s granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet 1990 336 :709-11.

 

Hirsch Index per 1 juli 2016: 55

Aantal citaties per 1 juli 2016:  >12.000

Other Publications:

1.         Cohen Tervaert JW, Kallenberg CGM. Anticytoplasmatic antibody in Wegener's Granulomatosis. Am Rev Respir Dis, 1987;135:767.

2.         Cohen Tervaert JW, van der Woude FJ, Kallenberg CGM. De ziekte van Wegener: een ernstige aandoening met een sluipend begin. Ned Tijdschr Geneesk, 1987;131:1391-1394.

3.         Cohen Tervaert JW, van der Woude FJ, Kallenberg CGM. Vasculitis: een spectrum van uiteenlopende ziektebeelden met gemeenschappelijke pathogenese. Ned Tijdschr Geneesk, 1987;131:2097-2098.

4.         Ter Borg EJ, Cohen Tervaert JW, Hollema H, et al. Een patient met poly¬chrondritis recidivans, vasculitis en lokale focale glomerulo¬nefritis. Ned Tijdschr Geneesk, 1988;132:584-586.

5.         Cohen Tervaert JW, Goldschmeding R, Hene RJ, Kallenberg CGM. Neutrophil cytoplasmic antibodies and Wegener's Granulomatosis. Lancet, 1989;i:270.

6.         Cohen Tervaert JW, Huitema MG, van der Giessen M, Goldschmeding R, van der Woude FJ, Kallenberg CGM. Wegener's Granulomatosis and anticyto-plasmic antibodies: the Groningen experience. APMIS, 1989;97:(S6) 36.

7.         Cohen Tervaert JW, van der Woude FJ, Fauci AS, Ambrus JL, Velosa J, Keane WF, Meijer S, van der Giessen M, The TH, van der Hem GK, Kallenberg CGM. Association between active Wegener's Granulomatosis and anticytoplasmic antibodies. Arch Int Med, 1989;149:2461-2465.

8.         Gans ROB, Goldschmeding R, Donker AJM, Hoorntje SJ, Kuizinga MC, Cohen Tervaert JW, Kallenberg CGM, von dem Borne AEGKr. Neutrophil cytoplasmic autoantibodies and Wegener's Granulomatosis. Lancet, 1989;i:269-270.

9.         Giessen van der M, Huitema MG, Cohen Tervaert JW, Kallenberg CGM. A technical note on the routinely performed ANCA detection. APMIS, 1989;97:(S6)37.

10.       Goldschmeding R, Cohen Tervaert JW, van der Schoot CE, van der Veen C, Kallenberg CGM, von dem Borne AEGKr. ANCA, anti-myelope¬roxidase, and elastase: three members of a novel class of autoantibodies against myeloid lysosomal enzymes. APMIS, 1989;97:(S6)48-49.

11.       Kallenberg CGM, Cohen Tervaert JW, Huitema MG, van der Giessen M. Towards standard sera for the determination of antineutrophil cytoplasmic (ANCA) and anti-myeloperoxidase (aMPO) antibodies. APMIS, 1989;97:(S6)14-15.

12.       Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a new class of autoantibodies in vasculitis and glomerulonephritis. Academic Thesis. Groningen, The Netherlands, 1990. (cum laude)

13.       Cohen Tervaert JW, Elema JD, Kallenberg CGM. Clinical and histopatholo-gical associations of 29 kD-ANCA and MPO-ANCA. APMIS, 1990;(S19)98:35.

14.       Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, van der Hem GK, von dem Borne AEGKr, Kallenberg CGM. Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulo-nephritis. Kidney Int, 1990;37:799-806.

15.       Cohen Tervaert JW, Goldschmeding R, Elema JD, van der Giessen M, Huitema MG, Koolen MI, Hene RJ, The TH, van der Hem GK, von dem Borne AEGKr, Kallenberg CGM. Association of autoantibodies to myeloperoxidase with different forms of vasculitis. Arthritis Rheum, 1990;33:1264-1272.

16.       Cohen Tervaert JW, Huitema MG, Hene RJ, Sluiter WJ, The Th, van der Hem GK, Kallenberg CGM. Prevention of relapses of Wegener's Granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre. Lancet, 1990;336:709-711.

17.       Goldschmeding R, Cohen Tervaert JW, Gans ROB, Dolman KM, van den Ende ME, Kuizinga MC, Kallenberg CGM, von dem Borne AEGKr. Different immunological specificities and disease assocations of c-ANCA and p-ANCA. Neth J Med, 1990;36:114-116.

18.       Kallenberg CGM, Cohen Tervaert JW, Stegeman CA. Criteria for disease activity in Wegener's Granulomatosis: a requirement for longitudinal clinical studies. APMIS, 1990;(S19) 98:37-39.

19.       Kallenberg CGM, Goldschmeding R, Cohen Tervaert JW, von dem Borne AEGKr. Autoantibodies to myeloid lysosomal enzymes: new clues to vasculitis and glomerulonephritis. A hypothesis based on humoral immune mechanisms. Neth J Med, 1990;36:163-168.

20.       Brouwer E, Cohen Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CGM. Predominance of IgG1 and IgG4 subclass of antineutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's Granulomatosis and clinically related disorders. Clin Exp Immunol, 1991;83:379-386.

21.       Cohen Tervaert JW. Antineutrofiele cytoplasmatische antistoffen: een nieuwe klasse van autoantistoffen. Analyse, 1991;46:213-216.

22.       Cohen Tervaert JW, Goldschmeding R, Elema JD, von dem Borne AEG¬Kr, Kallenberg CGM. Anti-myeloperoxidase antibodies in the Churg Strauss Syndrome. Thorax, 1991;46:70-71.

23.       Cohen Tervaert JW, Kallenberg CGM. Vasculitis. In: The TH, Kallenberg CGM, de Ley L (eds) Klinische Immunologie. Houten/Antwerpen, Bohn Stafleu Van Loghum, 1991.

24.       Cohen Tervaert JW, Limburg PC, Elema JD, Huitema MG, Horst G, The TH, Kallenberg CGM. Autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven arteritis. Am J Med, 1991;91:59-66.

25.       Goldschmeding R, Cohen Tervaert JW, Dolman KM, von dem Borne AEGKr, Kallenberg CGM. ANCA: a class of vasculitis-associated autoan¬tibodies against myeloid granular proteins: clinical and laboratory aspects and possible pathogenetic implications. Adv Exp Med Biol, 1991;297:129-139.

26.       Kallenberg CGM, Cohen Tervaert JW, Limburg PC. ELISA for detection of antibodies against neutrophil cytoplasm antigens. In: Bullock G, van Velzen D, Warhol MJ, Herbrink P (eds). Techniques in diagnostic pathology, vol. II. Academic Press Limited (London/San Diego), 1991;43-60.

27.       Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGKr, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today, 1991;12:61-64.

28.       Cohen Tervaert JW. Autoantibodies in systemic vasculitis. Aust NZ J Med, 1992;22:171-172.

29.       Cohen Tervaert JW. Vertraagt een eiwitbeperkt dieet het verlies van nierfunctie wel? Ned Tijdschr Geneeskd, 1992;136:2143-2144.

30.       Cohen Tervaert JW, Mulder AHL, Horst G, Haagsma EB, Kleibeuker JH, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis, ulcerative colitis, and autoimmune diseases. Gastroenterology, 1992;102:1090.

31.       Kallenberg CGM, Cohen Tervaert JW. Anti-neutrophilic cytoplasmic antibo¬dies: new tools in the diagnosis and follow-up of necroti¬zing glome¬rulonephritis. Springer-Verlag (London) 1991. In: Andreucci & Fine (eds). International Yearbook of Nephrology, 1992:313-335.

32.       Kallenberg CGM, Mulder AHL, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med, 1992;93:675-682.

33.       Brouwer E, Huitema MG, Klok PA, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model. J Exp Med, 1993;177:905-914.

34.       Brouwer E, Weening JJ, Klok PA, Huitema MG, Cohen Tervaert JW, Kallen¬berg CGM. Induction of a humoral and cellular (auto) immune response to human and rat myeloperoxidase (MPO) in Brown-Norway (BN), Lewis and Wistar Kyoto (WKY) rat strains. Adv Exp Med Biol, 1993;336:139-142.

35.       Cats HA, Cohen Tervaert JW, van Wijk R, Limburg PC, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies in giant cell arteritis and polymyalgia rheumatica. Adv Exp Med Biol, 1993;363-366.

36.       Cohen Tervaert JW. Detection and clinical associations of autoantibodies to myeloid granular proteins. Adv Exp Med Biol, 1993;336:299-302.

37.       Cohen Tervaert JW, Kallenberg CGM. Anti-myeloperoxidase antibodies in Churg-Strauss syndrome. J Neurol,1993;240:449-452.

38.       Cohen Tervaert JW, Kallenberg CGM. Neurologic manifestations of systemic vasculitides. Rheum Dis Cin North Am, 1993;19:913-940.

39.       Cohen Tervaert JW, Mulder AH, Stegeman CA, Huitema MG, The TH, Kallen¬berg CGM. The occurrence of autoantibodies to human leukocyte elastase in Wegener's granulomatosis and other inflammatory disorders. Ann Rheum Dis, 1993;52:115-120.

40.       Cohen Tervaert JW, Mulder AHL, Kallenberg CGM. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and its relation to antibodies against myeloid lysosomal enzymes. Adv Exp Med Biol, 1993;336:253-256.

41.       Kallenberg CGM, Cohen Tervaert JW. Positive ANCA and diagnosis of systemic vasculitis. Clin Nephrol, 1993;39:113-114.

42.       Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM. Serum markers of T-cell activation in relapses of Wegener's granulomatosis. Clin exp Immunol, 1993;91:415-420.

43.       Stegeman CA, Cohen Tervaert JW, Huitema MG, Kallenberg CGM: Serum markers of T-cell activation during relapses of Wegener's granulomatosis. Adv Exp Med Biol, 1993;336:389-392.

44.       Broekroelofs J, Mulder AHL, Nelis GF, Westerveld BD, Cohen Tervaert JW, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies in sera from patients with inflammatory bowel disease: relation to disease pattern and disease activity. Dig Dis Sci, 1994;39:545-549.

45.       Brouwer E, Huitema MG, Mulder AHL, Heeringa P, van Goor H, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Neutrophil activation in vitro and in vivo in Wegener's Granulomatosis. Kidney Int, 1994;45:1120-1131.

46.       Cohen Tervaert JW, Stegeman CA, Huitema MG, Kallenberg CGM. Comments on article of Kerr et al. Arthritis Rheum, 1994;37:596-597.

47.       Cohen Tervaert JW, Stegeman CA, Brouwer E, Mulder AHL, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies: a new class of autoantibodies in glomerulonephritis, vasculitis, and other inflammatory disorders. Neth J Med, 1994;45:262-272.

48.       Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int, 1994;46:1-15.

49.       Stegeman CA, Cohen Tervaert JW, Huitema MG, de Jong PE, Kallenberg CGM. Serum levels of soluble adhesion molecules intercellular adhesion molecule 1, vascular cell adhesion molecule 1, and E-selectin in patients with Wegener's granulomatosis. Relationship to disease activity and relevance during follow-up. Arthritis Rheum, 1994;37:1228-1235.

50.       Stegeman CA, Cohen Tervaert JW, Kallenberg CGM. Anti-neutrophil cytoplasmic antibodies (ANCA): tools for diagnosis and follow-up in systemic vasculitis. Ann Med Int, 1994;145: 523-532.

51.       Stegeman CA, Cohen Tervaert JW, Kallenberg CGM. Nasal carriage of Staphylococcal infection in Wegener granulomatosis. Ann Int Med, 1994;121:75.

52.       Stegeman CA, Cohen Tervaert JW, Manson WL, Sluiter WJ, de Jong PE, Kallenberg CGM. Chronic nasal carriage of Staphylococcal aureus in Wege¬ner's Granulomatosis identifies a subgroup of patients more prone to relapses. Ann Int Med, 1994;120:12-17.

53.       Stegeman CA, Cohen Tervaert JW, van Son WJ, Tegzess AM. Necrotizing glomerulonephritis associated with anti-myeloperoxidase antibodies in a renal transplant recipient with renal failure of unknown origin. Nephrol Dial Transplant, 1994;9:839-842.

54.       Hagen EC, Stegeman CA, d'Amaro J, Schreuder GMT, van Es LA, Cohen Tervaert JW, Kallenberg CGM, van der Woude FJ. Decreased frequency of HLA DR6/DR13 in patients with Wegener's granuloma¬tosis. Kidney Int, 1995;48:801-805.

55.       Kallenberg CGM, Brouwer E, Mulder AHL, Stegeman CA, Weening JJ, Cohen Tervaert JW. ANCA-pathophysiology revisited. Clin Exp Immunol, 1995;100:1-3.

56.       Rasmussen N, Jayne DRW, Abramowicz D, Andrassy K, Bacon PA, Cohen Tervaert JW, et al. European therapeutic trials in ANCA-associated systemic vasculitis. Disease scoring, consensus regimens and proposed clinical trials. Clin Exp Immu¬nol, 1995;101: supplement 1:29-34.

57.       Cohen Tervaert JW. De behandeling van vasculitis. Folia Pharmaceutica, 1996;83:35-39.

58.       Cohen Tervaert JW. The value of serial ANCA testing during follow-up studies in patients with ANCA-associated vasculitides. A review. J Nephrol, 1996;9:232-240.

59.       Cohen Tervaert JW, Kallenberg CGM. The role of autoimmunity to myeloid lysosomal enzymes in the pathogenesis of vasculitis. In: Hansson GK, Libby P (eds) Immune functions of the vessel wall. Harwood Academic Publishers, London, 1996;99-120. ISBN 3-7186-5891-7

60.       Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides. Sarcoidosis vasculitis and diffuse lung diseases, 1996;13:241-245.

61.       Franssen CFM, Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Comment on article by Rao et al. Lancet, 1996;347:116.

62.       Kallenberg CGM, Stegeman CA, Cohen Tervaert JW. Staphylococcus aureus, Trimethoprim-Sulfamethoxazole, and Wegener's granulomatosis. Sarcoidosis, vasculitis, and diffuse lung diseases, 1996;13:253-255.

63.       Spronk PE, Horst G, Huitema MG, Limburg PC, Cohen Tervaert JW, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in Systemic Lupus Erythematosus. Br J Rheumatol, 1996;35:625-631.

64.       Stegeman CA, Cohen Tervaert JW, De Jong PE, Kallenberg CGM. Trimethop¬rim-sulfamethoxazole (Co-trimoxazole) for the prevention of relap¬ses of Wegener's granuloma¬tosis. N Engl J Med, 1996;335:16-20.

65.       Stegeman CA, Cohen Tervaert JW, Kallenberg CGM. Co-trimoxazole in Wege¬ner's granulomatosis. (Letter) N Engl J Med, 1996;335:1786.

66.       Belizna C, Cohen Tervaert JW. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Seminars Arthritis Rheum, 1997;27:98-109.

67.       Cohen Tervaert JW, Kallenberg CGM. Cell adhesion molecules in vasculitis. Curr Opin Rheum, 1997;9:16-25.

68.       Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Wat is de onderhoudsbe¬handeling van de Ziekte van Wegener? Hoe dient de controle plaats te vinden, hoelang dient de behandeling te duren en hoe moet de therapie worden afgebouwd? Internisten Vademecum, 1997;14:1-3.

69.       Heeringa P, Foucher P, Klok PA, Huitema MG, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut. Am J Pathol, 1997;151:131-140.

70.       Jayne DRW, Rasmussen N, Abramowicz D, Tesar V, Rasmussen N, Petersen J, Juhl BR, Wiik A, GronhagenRiska C, Guillevin L, Lhote F, Landais P, Lesavre P, Vanhille P, Andrassy K, Groot de K, Gross WL, Woude van der F, Boki KA, Cohen Tervaert JW, Kallenberg CGM, Es van LA, Hermans J, Siegert C, Hagen EC, Feighery CF, Gregorini G, Ferrario F, Sinico RA, Dadoniene J, Vasconcelos C, Mirapeix E, Heigl Z, Pettersson EE, Westman KWA, Bacon PA, Savage COS, Jayne DRW, Lockwood CM, Luqmani RA, Gaskin G, Pusey CD, Specks U. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: Initiatives of the european community systemic vasculitis clinical trials study group. Mayo Clin Proc, 1997;72:737-747.

71.       Stegeman CA, Cohen Tervaert JW. Contemporary diagnosis and managemnet of Wege¬ner's granulomatosis. Curr Opin Otolaryngology & Head and Neck Surgery, 1997;5: 181-186.

72.       Stegeman CA, Cohen Tervaert JW, Kallenberg CGM. Co-t¬rimoxazole and Wege¬ner's granulomatosis: more than a coincidence? Nephrol Dial Transplant, 1997;12:652-655.

73.       Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Silicon exposure and vasculitis. Curr Opin Rheumatol, 1998;10:12-17.

74.       Cohen Tervaert JW, van der Werff TS, Stegeman CA, Timens W, Kallenberg CGM. Pulmonary manifestations of systemic vasculitides. In: Isenberg DA, Spiro SG (eds). Autoimmune aspects of lung disease. Birkhaüser Verlag, Basel, 1998;53-85.¬

75.       Franssen CFM, Stegeman CA, Oost-Kort WW, Kallenberg CGM, Limburg PC, Tiebosch A, de Jong PE, Cohen Tervaert JW. Determinants of renal outcome in anti-myeloperoxidase associated necrotizing crescentic glomerulonephritis. J Am Soc Nephrol, 1998;9:1915-1923.

76.       Heeringa P, Brouwer E, Cohen Tervaert JW, Weening JJ, Kallenberg CGM. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int, 1998;53:253-263.

77.       Kallenberg CGM, Cohen Tervaert JW. Immunologie in de medische praktijk. IX. Systemische vasculitis. Ned Tijdschr Geneeskunde, 1998;142: 118-123.

78.       Kallenberg CGM, Heeringa P, Cohen Tervaert JW. Are anti-neutrophil cytoplas¬mic antibodies pathogenic in Wegener's granulomatosis? Lessons from in vitro and in vivo findings. In: Y Schoenfeld, ed. The Decade of Autoimmunity. Elsevier Science BV, 1998;219-226.

79.       Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Leukocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wege¬ner's granulomatosis. Br J Rheumatol, 1998;37:901-907.

80.       Muller Kobold AC, Mesander G, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. Are circulating neutrophils intravascularly activated in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides? Clin Exp Immunol, 1998;114:491-499.

81.       Muller Kobold AC, Tulleken JE, Zijlstra JG, Cohen Tervaert JW. Interleukin 10 in febrile patients and sepsis. Lancet, 1998;351:1587.

82.       Muller Kobold AC, Zijlstra JG, Koene HR, de Haas M, Kallenberg CGM, Cohen Tervaert JW. Levels of soluble FcgammaRIII correlate with disease severity in sepsis. Clin Exp Immunol, 1998;114:220-227.

83.       Roozendaal C, Van Milligen de Wit AWM, Haagsma EB, Horst G, Schwarze C, Peter HH, Kleibeuker JH, Cohen Tervaert JW, Limburg PC, Kallenberg CGM. Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features. Am J Med, 1998;105:393-399.

84.       Weening JJ, Heeringa P, Brouwer E, Cohen Tervaert JW, Kallenberg CGM. Vascularites systémiques associées aux ANCA: modeles animaux et leur intérêt clinique. Adv Nephrol Necker Hosp, 1998;28:63-81.

85.       Boomsma MM, Stegeman CA, Cohen Tervaert JW. Comparison of Dutch and US patients' perceptions of the effects of Wegener's granulomatosis on health, function, income and interpersonal relations¬hips: comment on the article by Hoffman et al. Arthritis Rheum, 1999;42:2495-2497.

86.       Brijker F, Magee C, Cohen Tervaert JW, Murphy R, Walshe J. Outcome analysis of patients with vasculitis associated with anti-neutrophil cytoplasmic antibodies. Clin Nephrol, 1999;52:344-351.

87.       Choi HK, Merkel P, Cohen Tervaert JW, Black RM, McCluskey RT, Niles JL. Alternating ANCA vasculitides. Drug-induced vasculitis in a patient with Wegener's granulomatosis. Artritis Rheum, 1999;42:384-388.

88.       Cohen Tervaert JW, Kolkman JJ. Mesenteriale afwijkingen bij gegeneraliseerde vaatziekten. In: Van Lanschot JJB, Gouma DJ, Schouten WR, Tytgat GNJ, Jansen PLM (eds). Gastro-Intestinale Chirurgie en gastro-enterologie in onderling verband. Bohn Stafleu Van Loghum, Houten/Diegem, 1999;323-325.

89.       Cohen Tervaert JW, Popa ER, Bos NA. The role of superantigens in vasculitis. Curr Opin Rheumatol, 1999;11:24-33.

90.       Dijstelbloem HM, Scheepers RHM, Oost WW, Stegeman CA, van der Pol WL, Sluiter WJ, Kallenberg CGM, van de Winkel JGJ, Cohen Tervaert JW. Fc gamma polymorphisms in Wegener's granulomatosis. Arthritis Rheum, 1999;42:1823-1827.

91.       Foucher P, Heeringa P, Petersen AH, Huitema MG, Brouwer E, Cohen Tervaert JW, Prop J, Camus P, Weening JJ, Kallenberg CGM. Anti-myeloperoxidase associated lung disease;an experimental model. Am J Resp Crit Care Med, 1999;160:987-994.

92.       Franssen CFM, Huitema MG, Muller Kobold AC, Oost-Kort WW, Limburg PC, Tiebosch A, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. In vitro activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis. J Am Soc Nephrol, 1999;10:1506-1515.

93.       Haveman JW, Muller Kobold AC, Cohen Tervaert JW, van den Berg AP, Tulleken JE, Kallen-berg CGM, The TH. New insights in the pathophysiology of sepsis: importance of immunomonitoring for prognosis and therapy. Neth J Med, 1999;55:132-141.

94.       Kallenberg CGM, Cohen Tervaert JW. What is new with anti-neutrophil cyto¬plasm antibodies: diagnostic, pathogenetic and therapeutic implications. Curr Opin Nephrol Hypertens, 1999;8:307-315.

95.       Muller Kobold AC, Van der Geld Y, Limburg PC, Cohen Tervaert JW, Kallenberg CGM. Molecular basis of renal disease: Pathophysiology of ANCA-associa¬ted glomerulonephritis. Nephrol Dial Transplant, 1999;14:1366-1375.

96.       Muller Kobold AC, Kallenberg CGM, Cohen Tervaert JW. Monocyte activation in Wegener's granulomatosis. Ann Rheum Dis, 1999;58:237-245.

97.       Muller Kobold AC, van Wijk RT, Franssen CFM, Molema G, Kallenberg CGM, Cohen Tervaert JW. In vitro upregulation of E-selectin and induction of interleu¬kin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Rheumatol, 1999;17:433-440.

98.       Popa ER, Stegeman CA, Bos NA, Kallenberg CGM, Cohen Tervaert JW. Differential B- and T-cell activation in Wegener's granulomatosis. J Allergy Clin Immunol, 1999;103:885-894.

99.       Boomsma MM, Stegeman CA, van der Leij MJ, Oost W, Hermans J, Kallenberg CGM, Limburg PC, Cohen Tervaert JW. Prediction of relapses in Wegener’s granulomatosis by measurement of Anti-Neutrophil Cytoplasmic Antibody levels;a prospective study. Arthritis Rheum, 2000;43:2025-2033.

100.     Brons RH, Bakker HI, van Wijk RT, van Dijk NW, Muller Kobold AC, Limburg PC, Manson WL, Kallenberg CGM, Cohen Tervaert JW. Staphylococcal acid phosphatase binds to endothelial cells via charge interaction;a pathogenic role in Wegener's granulomatosis? Clin Exp Immunol, 2000;119:566-573.

101.     Cohen Tervaert JW. Pathophysiological mechanisms in anti-myeloperoxidase associated vasculitis. In Nauseef WM, Petrides PE: The peroxidase multigene family of enzymes: Biochemical basis and clinical applications. Springer-Verlag, 2000;186-190.

102.     Cohen Tervaert JW. Proteinase 3: A cofactor for the binding of antineutrophil cytoplasm antibodies (ANCA) to endothelial cells? (editorial) Kidney Int, 2000;57:2171-2172.

103.     Cohen Tervaert JW, Kallenberg JW. Leukocyte cell adhesion molecules in vasculitis. In: Asherson, Cervera, Tripplet and Abramson. Vascular manifestations of systemic autoimmune diseases. CRC Press, 2000;161-178.

104.     Cohen Tervaert JW, Popa ER, Brons RH. Staphylococcus aureus, superantigens and vasculitis. Clin Exp Immunol, 2000;120(Suppl. 1):6-7.

105.     Fijen JW, Muller Kobold AC, de Boer P, Jones CR, van der Werf TS, Cohen Tervaert JW, Zijlstra JG, Tulleken JE. Leukocyte activation and cytokine produc¬tion during experimental human endotoxemia. Eur J Int Med, 2000, 11:89-95.

106.     Franssen CF, Stegeman CA, Kallenberg CGM, Gons ROB, de Jong PE, Hoorntje SJ, Cohen Tervaert JW. Anti-proteinase 3 and anti-myeloperoxidase associated vasculitis. Kidney Int, 2000;57:2195-2206.

107.     Hewins P, Cohen Tervaert JW, Savage COS, Kallenberg CGM. Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol, 2000;12:3-10.

108.     Kallenberg CGM, Cohen Tervaert JW. New treatments of ANCA-associated vasculitis. Sarcoidosis Vasc Diffuse Lung Dis, 2000;17:125-129.

109.     Kallenberg CG, Cohen Tervaert JW. What is new in systemic vasculitis? Ann Rheum Dis, 2000;59:924-925.

110.     Kas-Deelen AM, Harmsen MC, De Maar EF, Oost-Kort WW, Cohen Tervaert JW, Van Der Meer J, Van Son WJ, The TH. Acute rejection before cytomegalovirus infection enhances von willebrand factor and soluble VCAM-1 in blood. Kidney Int, 2000;58:2533-2542.

111.     Molema G, Cohen Tervaert JW, Kroesen BJ, Helfrich W, Meijer DKF, de Leij LFMH. CD3 directed bispecific antibodies induce increased lymphocyte - endothe¬lial cell intercations in vitro. Br J Cancer, 2000;82:472-479.

112.     Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CGM, Cohen Tervaert JW. Leukocyte activation in sepsis;correlations with disease state and mortality. Intensive Care Med, 2000;26:883-892.

113.     Stienstra Y, Fijen JW, Cohen Tervaert JW, Dankbaar H, Zijlstra JG, van der Werf TS. Longbloedingen met respiratoire insufficiëntie bij Henoch-Schönlein purpura. Ned Tijdschr Geneeskd, 2000;144:617-622.

114.     Boomsma MM, Stegeman CA, Kallenberg CGM, Cohen Tervaert JW. Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment. In: Kallenberg CGM, Cohen Tervaert JW, Disease-modifying Therapy in Vasculitides. 2001. Birkhäuser Verlag AG Basel/Switzerland, 2001:181-199.

115.     Boomsma MM, Stegeman CA, Oost-Kort WW, Kallenberg CG, Moguilevsky N, Limburg PC, Cohen Tervaert JW. Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis. J Immunol Methods, 2001;254:47-58.

116.     Brons RH, Jong de MC, Boer de NK, Stegeman CA, Kallenberg CG, Cohen Tervaert JW. Detection of immune deposits in skin lesions of patients with Wegener's granulomatosis. Ann Rheum Dis, 2001;60:1097-1102.

117.     Brons RH, Kallenberg CG, Cohen Tervaert JW. Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune? Rheumatic Disease Clinics of North America, 2001;27:833-848.

118.     Cohen Tervaert JW, Stegeman CA, Kallenberg CG. Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Nephrol Hypertens, 2001;10:211-217.

119.     Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Standard therapeutic regimens for vasculitis. In: Kallenberg CGM, Cohen Tervaert JW, Disease-modifying Therapy in Vasculitides. 2001. Birkhäuser Verlag AG Basel/Switzerland, 2001:21-40.

120.     Fijen JW, Zijlstra JG, Boer de P, Spanjersberg R, Cohen Tervaert JW, Werf van der TS, Ligtenberg JJ, Tulleken JE. Suppression of the clinical and cytokine response to endotoxin by RWJ- 67657, a p38 mitogen-activated protein-kinase inhibitor, in healthy human volunteers. Clin Exp Immunol, 2001;124:16-20.

121.     Geld van der YM, Simpelaar A, Zee van der R, Cohen Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CG. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Kidney Int, 2001;59:147-159.

122.     Haelst van P, Doormaal van JJ, May JF, Gans ROB, Crijns HJ, Cohen Tervaert JW. Secondary prevention with fluvastatin decreases levels of adhesion molecules, neopterin and C-reactive protein. Eur J Int Med, 2001;12:503-509.

123.     Heeringa P, Bijl M, Jager de-Krikken A, Zandvoort A, Dijkstra G, Moshage H, Cohen Tervaert JW, Tiebosch AT, Kallenberg CG, Goor van H. Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis. J Pathol, 2001;193:224-232.

124.     Kallenberg CGM, Cohen Tervaert JW. Disease-modifying Therapie in Vasculitides. Birkhäuser Verlag AG Basel/Switzerland, 2001.

125.     Kallenberg CGM, Cohen Tervaert JW. Systemic vasculitides, an introduction. In: Kallenberg CGM, Cohen Tervaert JW, Disease-modifying Therapy in Vasculitides. 2001. Birkhäuser Verlag AG Basel/Switzerland, 2001:1-19.

126.     Kallenberg C, Cohen Tervaert JW. Systemic Vasculitis. In: Molecular Pathology of autoimmunity, edited by Theofilopoulos AN, Bona CA. Publisher: Harwood Academic, 2001.

127.     Kreeftenberg HG, Ligtenberg JJM, Werf van der TS, Timens W, Cohen Tervaert JW. Pulmonary vasculitis may obscure large cell lung carcinoma. A case report. Clin Exp Rheumatolm, 2001;19:731-734.

128.     Leeuwen van EB, Wisman GB, Cohen Tervaert JW, Palmans LL, Wijk van RT, Veenstra R, Molema G, Zee van der AG, Meer van der J, Ruiters MH. An SV40 large T-antigen immortalized human umbilical vein endothelial cell line for anti-endothelial cell antibody detection. Clin Exp Rheumatol, 2001;19:283-290.

129.     Rutgers A, Cohen Tervaert JW. Hoe groot is de kans op een vasculitis bij een normale BSE en CRP? Reumatologen vademecum, juli 2001 no. 7.

130.     Rutgers A, Cohen Tervaert JW. Hoe groot is de kans op een vasculitis bij een normale BSE en CRP? Internisten vademecum, december 2001 no. 20.

131.     Swets BP, Brouwer DA, Cohen Tervaert JW. Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin Exp Immunol, 2001;124:163-167.

132.     Barendrecht MM, Cohen Tervaert JW, Breda Vriesman van PJ, Damoiseaux JG. Susceptibility to Cyclosporin A-induced Autoimmunity: Strain Differences in Relation to Autoregulatory T Cells. J Autoimmun, 2002;18:39-48.

133.     Bemelmans WJ, Lefrandt JD, Feskens EJ, Broer J, Cohen Tervaert JW, May JF, Smit AJ. Change in saturated fat intake is associated with progression of carotid and femoral intima-media thickness, and with levels of soluble intercellular adhesion molecule-1. Atherosclerosis, 2002;163:113-120.

134.     Boomsma MM, Bijl M, Stegeman CA, Kallenberg CG, Hoffman GS, Cohen Tervaert JW. Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis. Arthritis Rheum, 2002;47:196-201.

135.     Boomsma MM, Stearns-Kurosawa DJ, Stegeman CA, Raschi E, Meroni PL, Kurosawa S, Cohen Tervaert JW. Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis. Clin Exp Immunol, 2002;128:187-194.

136.     Boomsma MM, Stegeman CA, Kramer AB, Karsijns M, Piers DA, Cohen Tervaert JW. Prevalence of reduced bone mineral density in patients with anti-neutrophil cytoplasmic antibody associated vasculitis and the role of immunosuppressive therapy: a cross-sectional study. Osteoporos Int, 2002;13:74-82.

137.     Cohen Tervaert JW. Infections in primary vasculitides. Cleve Clin J Med, 2002:SII24-26.

138.     Cohen Tervaert JW, Boeve WJ, Kolkman JJ, Cate Hoedemaker ten HO, Stegeman CA. Gastro-intestinale chirurgie en gastro-enterologie. XIV. Mesenteriale afwijkingen bij gegeneraliseerde vaatziekten. Ned Tijdschr Geneeskd, 2002;146:250-255.

139.     Cohen Tervaert JW, Damoiseaux J, Boomsma MM, Stegeman CA. Absence of anti-cyclic citrullinated peptide antibodies in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum, 2002;46:849-850.

140.     Damoiseaux JGMC, Bouten B, Linders AMLW, Austen J, Roozendaal C, Russel MGVM, Forget P-PH, Cohen Tervaert JW. Diagnostic Value of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol, 2002;22:281-288.

141.     Damoiseaux JGMC, Cohen Tervaert JW. The definition of autoimmune disease: are Koch’s postulates applicable? Neth J Med, 2002;60:266-268.

142.     Damoiseaux, JGMC and Cohen Tervaert JW. Celiac disease: the role of (auto)antibody detection in diagnosis and follow-up. Neth J Med, 2002;60:303-304.

143.     Dijkstra G, Zandvoort AJH, Muller Kobold AC, Jager de – Krikken A, Heeringa P, Goor van H, Dullemen van HM, Cohen Tervaert JW, Loosdrecht van de A, Moshage H, Jansen PLM. Increased expression of inducible nitric oxide synthase in circulating monocytes from patients with active inflammatory bowel disease. Scand J Gastroenterol, 2002;5:546-554.

144.     Geld van der YM, Tool ATJ, Videler J, Haas de M, Cohen Tervaert JW, Stegeman CA, Limburg PC, Kallenberg CGM, Roos D. Interference of PR3-ANCA with the enzymatic of PR3: differences in patients during active disease or remission of Wegener’s granulomatosis. Clin Exp Immunol, 2002;129:562-570.

145.     Haelst van PL, Asselbergs FW, Doormaal van JJ, Veeger NJ, May JF, Holvoet P, Gans RO, Cohen Tervaert JW. Antineutrophil cytoplasmatic antibodies in patients with premature atherosclerosis: prevalence and association with risk factors. J Intern Med, 2002;251:29-34.

146.     Haelst van PL, Muller Kobold AC, Doormaal van JJ, Cohen Tervaert JW. Aeca and anca in patients with premature atherosclerosis. Intern Rev Immunol, 2002;21:19-26.

147.     Heeringa P, Cohen Tervaert JW. Role of oxidized low-density lipoprotein in renal disease. Curr Opin Nephrol Hypertens, 2002;11:287-293.

148.     Kallenberg CGM, Cohen Tervaert JW. “Renal Manifestations”. In: Vasculitis, edited by Ball GV and Bridges L jr. Publisher: Oxford University Press, 2002;139-149.

149.     Kallenberg CG, Cohen Tervaert JW. “Autoantibodies in Vasculitis”. In: Inflammatory Diseases of Blood Vessels, edited by Hoffman G, Weyand C. Publisher: Marcel Dekker, Inc., New York, USA, 2002;4:37-56.

150.     Kallenberg CG, Cohen Tervaert JW. “Systemic Vasculitis”. In: The Molecular Pathology of Autoimmune Diseases (second edition), edited by Theofilopoulos AN and Bona CA. Publisher: Taylor & Francis, New York, USA, 2002;483-503.

151.     Popa ER, Franssen CFM, Limburg PC, Huitema MG, Kallenberg CGM, Cohen Tervaert JW. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase. Arthritis Rheum, 2002;46:1894-1904.

152.     Popa ER, Stegeman CA, Kallenberg CG, Cohen Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res, 2002;4:77-79.

153.     Reynolds WF, Stegeman CA, Cohen Tervaert JW. -463 G/A Myeloperoxidase Promoter Polymorphism Is Associated with Clinical anifestations and the Course of Disease in MPO-ANCA-Associated Vasculitis. Clin Immunol, 2002;103:154-160.

154.     Ven van der A, Bruggeman C, Cohen Tervaert JW. Chlamydia pneumoniae infection: Which role in atherosclerosis? Arch intern med, 2002;162:2140-2141.

155.     Ven van der AJ, Oostenbrugge van RJ, Cohen Tervaert JW. Two patients with isolated vasculitis of the central nervous system. Ned Tijdschr Geneeskd, 2002;146:1300-1301.

156.     Ven van der AJ, Oostenbrugge van RJ, Kubat B, Cohen Tervaert JW. Cerebral vasculitis after initiation antiretroviral therapy. AIDS, 2002;16:2362-2364.

157.     Vonk MC, Wollersheim H, Cohen Tervaert JW. “Vasculitis”. In: Vasculaire Geneeskunde, edited by Buller et al. Publisher: van Zuiden communications, 2002;323-348.

158.     Boomsma MM, Damoiseaux JG, Stegeman CA, Kallenberg CG, Patnaik M, Peter JB, Cohen Tervaert JW. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods, 2003;274:27-35.

159.     Cohen Tervaert JW. ANCA testing in monitoring the activity of the disease. Kidney Blood Press Res, 2003;26:226-230.

160.     Cohen Tervaert JW, Heeringa P. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic? Neth J Med, 2003;61:404-407.

161.     Cohen Tervaert JW, Leeuw de P. Renal protection from glomerular fibrosis. J Hypertens, 2003;21:687-689.

162.     Cohen Tervaert JW, StegemanCA. Behandeling van patiënten met de ziekte van Wegener, dan wel ANCA-geassocieerde vasculitis. Ned Tijdschr Geneeskd, 2003;147:2265-2267.

163.     Delen S, Boonen A, Landewé R, Kroon AA, Linden van der Sj, Cohen Tervaert JW. An unusual case of ANCA positive disease. Ann Rheum Dis, 2003;62:770-781.

164.     Haelst van P, Cohen Tervaert JW, Geel van P, Veeger N, Gurné O, Gans R, Gilst van W. Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1. Eur J Vasc Endovasc Surg, 2003;26:387-391.

165.     Haelst van P, Doormaal van J, Asselbergs F, Roon van A, Veeger N, Henneman M, Smit A, Cohen Tervaert JW, May J, Gans R. Correlates of endothelial function and their relationship with inflammation in patients with familial hypercholesterolaemia. Clinical Science, 2003;104:627-632.

166.     Haelst van P, Liem A, Boven van A, Veeger N, Veldhuizen van D, Cohen Tervaert JW, Gans RO, Zijlstra F. Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction. Am J Cardiol, 2003;92:1201-1203.

167.     Jayne D, Rasmussen N, Andrassy K, Bacon P, Cohen Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, Groot de K, Gross W, Hagen E, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey Ch. A randomised trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med, 2003;349:36-44.

168.     Paassen van P, Damoiseaux J, Cohen Tervaert JW. Laboratory assessment in musculoskeletal disorders. Best Pract Res Clin Rheumatol, 2003;3:475-494.

169.     Popa E, Cohen Tervaert JW. The relation between staphylococcus aureus and Wegener’s Granulomatosis: Current knowledge and future directions. Int Med, 2003;42:711-780.

170.     Popa E, Stegeman C, Bos N, Kallenberg C, Cohen Tervaert JW. Staphylococcal superantigens and T cell expansions in Wegener’s granulomatosis. Clin Exp Immunol, 2003;132:496-504.

171.     Rothkrantz-Kos S, Drent M, Rutgers A, Heeringa P, Vries de J, Dieijen-Visser van M, Cohen Tervaert JW. Relationship between myeloperoxidase promotor polymorphism and disease severity in sarcoidosis. Eur J Intern Med, 2003;14:296-301.

172.     Rutgers A, Heeringa P and Cohen Tervaert JW. The role of myeloperoxidase in the pathogenesis of systemic vasculitis. Clin Exp Rheumatol, 2003;21:S55-S63.

173.     Rutgers A, Heeringa P, Damoiseaux J, Cohen Tervaert JW. ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease. Eur J Intern Med, 2003;14:287-295.

174.     Rutgers A, Heeringa P, Giesen J, Theunissen R, Jacobs H, Cohen Tervaert JW. Neutrophil myeloperoxidase activity and the influence of two single-nucleotide promoter polymorphisms. Br J Haematol, 2003;123:536-538.

175.     Rutgers A, Heeringa P, Kooman JP, Sande van der FM, Cohen Tervaert JW. Peripheral blood myeloperoxidase activity increases during hemodialysis. Kidney Int, 2003;64:760.

176.     Slart RH, Jager PL, Poot L, Piers DA, Cohen Tervaert JW, Stegeman CA. Clinical value of gallium-67 scintigraphy in assessment of disease activity in Wegener's granulomatosis. Ann Rheum Dis, 2003;62:659-662.

177.     Slot MC, Cohen Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int, 2003;63:670-677.

178.     Assche van G, Geboes K, Cohen Tervaert JW. Vascular disorders of the distal gastrointestinal tract. In: Integrated Medical and Surgical Gastroenterology, edited by Lanschot van J, Gouma D et al. Publisher: Bohn Stafleu Van Loghum, Houten. 2004;315-326;

179.     Asselsbergs FW, Cohen Tervaert JW, Tio RA. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med, 2004;350:516-518.

180.     Asselbergs FW, Reynolds WF, Cohen Tervaert JW, Jessurun GA, Tio RA. Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease. Am J Med, 2004;116:429-430.

181.     Bemelmans WJ, Lefrandt JD, Feskens EJ, Haelst v P, Broer J, Meyboom-De Jong B, May JF, Cohen Tervaert JW, Smit AJ. Increased alpha-linolenic acid intake lowers C-reactive protein, but has no effect on markers of atherosclerosis. Eur J Clin Nutr, 2004;58:1083-1089.

182.     Cohen Tervaert JW, Stegeman CA. A difficult diagnosis. Lancet, 2004;364:1313-1314.

183.     Cohen Tervaert JW, Stegeman C. Infections and vasculitis. In: Infection and autoimmunity, edited by Shoenfeld Y et al. Publisher: Elsevier B.V., Amsterdam. 2004;549-557;

184.     Csernok E, Holle J, Hellmich B, Cohen Tervaert JW, Kallenberg CG, Limburg PC, Niles J, Pan G, Specks U, Westman K, Wieslander J, De Groot K, Gross WL. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study. Rheumatology, 2004;43:174-180.

185.     Damoiseaux J, Cohen Tervaert JW. Autoantibodies, tests for. In: the Encyclopedic Reference of Immunotoxicology, edited by Vohr HW. Publisher: Springer Verlag. 2004;1-4;

186.     Damoiseaux, JGMC, Wijffels MCEF, Willems GM, Bevers EM, Spaanderman MEA, Pampus van ECM, Cohen Tervaert JW. The antiphospholipid/cofactor syndrome : results of routine screening for antibodies to 2-GPI upon suspicion of the antiphospholipid syndrome. Scand J Rheumatol, 2004;33:441-442.

187.     Haelst van P, Cohen Tervaert JW, Bijzet J, Balje-Volkers C, May J, Langeveld B, Gans R. Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation. Clin Exp Immunol, 2004;138:364-368.

188.     Heeringa P, Cohen Tervaert JW. Pathophysiology of ANCA-associated vasculitides: Are ANCA really pathogenic? Kidney Int, 2004;65:1564-1567.

189.     Heeringa P, Cohen Tervaert JW. Pathophysiology of ANCA-associated vasculitides: Are ANCA really pathogenic? A note of caution. Kidney Int, 2004;66:2090-2091. Letter to the Editor.

190.     Huugen D, Cohen Tervaert JW, Heeringa P. Antineutrophil cytoplasmic autoantibodies and pathophysiology: new insights from animal models. Curr Opin Rheumatol, 2004;16;4-8.

191.     Kallenberg C, Cohen Tervaert JW. Vasculitis. In: Reumatologie en Klinische Immunologie, edited by Bijlsma J et al. Publisher Bohn Stafleu van Loghum, Houten. 2004;132-150;

192.     Oomen PH, Kant GD, Dullaart RP, Cohen Tervaert JW, Reitsma WD, Smit AJ. No effects of acute hyperglycaemia and hyperinsulinaemia on skin microcirculation and endothelial markers in Type II diabetes mellitus. Scand J Clin Lab Invest, 2004;64:119-127.

193.     Paassen van P, Breda Vriesman van P, Rie van H, Cohen Tervaert JW. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry. Kidney Int, 2004;66:909-913.

194.     Rutgers A, Damoiseaux J, Roozendaal C, Limburg CP, Stegeman CA, Cohen Tervaert JW. ANCA-GBM Dot-Blot: Evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis. J Clin Immunol, 2004;24:435-440.

195.     Slot M, Cohen Tervaert JW. Wegener’s granulomatosis. Autoimmunity, 2004;37:313-315.

196.     Slot M, Cohen Tervaert JW, Boomsma M, Stegeman C. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis. Arthritis Rheum, 2004;51:269-273.

197.     Smedema J, Paassen van P, Kroonenburgh M, Snoep G, Crijns H, Cohen Tervaert JW. Cardiac involvement of churg strauss syndrome demonstrated by magnetic resonance imaging. Clin Exp Rheumatol, 2004;22:S75-S78.

198.     Vonk M, Wollersheim H, Cohen Tervaert JW. Vasculitis. In: Vasculaire Geneeskunde, edited by Büller H et al. Publisher: Van Zuiden Communications BV, Alphen Aan den Rijn. 2004;363-386;

199.     Austen J, Damoiseaux J, Cohen Tervaert JW. Immunologische diagnostiek bij snel progressieve glomerulonefritis. Analyse, juni 2005:144-148.

200.     Cohen Tervaert JW, Damoiseaux JGMC. Autoimmunity-vasculitis. In: Measuring Immunity, edited by Lotz,. Publisher Elsevier. 2005;560-568.

201.     Damoiseaux J, Boesten K, Giesen J, Austen J, Cohen Tervaert JW. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens. Ann N Y Acad Sci, 2005;1050:340-347.

202.     Damoisaeux J, Cohen Tervaert JW. Tests for autoantibodies. In: Encyclopaedic reference of immunotoxicology, edited by Vohr. Publisher Springer-Verlag, Heidelberg, Duitsland. 2005;68-72.

203.     Damoiseaux J, Jeyasekharan A, Theunissen R, Cohen Tervaert JW. Cross-reactivity of IgM and IgG anticardiolipin antibodies with oxidized-low density lipoproteins. Ann N Y Acad Sci, 2005;1050:163-169.

204.     Damoiseaux J, Slot M, Vaessen M, Stegeman C, Paassen van P, Cohen Tervaert JW. Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J Clin Immunol, 2005;25 :202-208.

205.     Damoiseaux J, Ven van der A, Hermsen R, Telgt D, Roestenberg M, Cohen Tervaert JW, Sauerwein R. Experimental infection with Plasmodium falciparum does not result in the induction of anticardiolipin antibodies in healthy volunteers. Ann Rheum Dis, 2005;64:1804-1805.

206.     Drijkoningen J, Cohen Tervaert JW. Heeft een neusslijmbiopt zin als slijmvlies er normaal uit ziet (bij suspectie M. Wegener)? Antwoord in Reumatologen Vademecum, maart 2005: no 5.

207.     Groot de K, Rasmussen N, Bacon P, Cohen Tervaert JW, Feighery C, Gregorini G, Gross W, Luqmani R, Jayne D. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum, 2005;52:2461-2469.

208.     Heeringa P, Huugen D, Cohen Tervaert JW. Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? Trends Immunol, 2005;26:561-564.

209.     Huugen D, Xiao H, Esch van A, Falk RJ, Peutz-Kootstra C, Buurman W, Cohen Tervaert JW, Jennette J, Heeringa P. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide. Am J Pathol, 2005;167:47-58.

210.     Rutgers A, Slot M, Paassen v. P, Breda Vriesman v. P, Heeringa P, Cohen Tervaert JW. Coexistence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase-ANCA in Crescentic Glomerulonephritis. Am J Kidney Dis, 2005;46: 253-62.

211.     Slot M, Links T, Stegeman C, Cohen Tervaert JW. Occurrence of antineutrophil cytoplasmic antibodies and associated vasculitis in patients with hyperthyroidism treated with antithyroid drugs: a long-term followup study. Arthritis Rheum, 2005;53:108-113.

212.     Smook M, Heeringa P, Damoiseaux J, Daemen M, Winther de M, Gijbels M, Beckers L, Lutgens E, Cohen Tervaert JW. Leukocyte CD40L deficiency affects the CD25+ CD4 T cell population but does not affect atherosclerosis. Atherosclerosis, 2005;183:275-82.

213.     Damoiseaux J, Cohen Tervaert JW. From ANA to ENA: How to proceed? Autoimmunity Reviews, 2006;5:10-17.

214.     Halm van VP, Slot MC, Nurmohamed MT, Cohen Tervaert JW, Dijkmans BA, Voskuyl AE. Antibodies against human 60-kDa heat-shock protein can not be associated with cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65:590-594.

215.     Milovanceva-Popovska M, Grcevska L, Dzikova S, Ristovska v, Petrusevska G, Stefanovski K, Tervaert JW, Polenakovic M. ANCA-GBM dot-blot test in diagnosis of patients with glomerulonephritis. Prilozi. 2006 Jul;27(1):45-55

216.     Nieuwhof CM, Damoiseaux J, Tervaert JW. Successful treatment of cerebral vasculitis in a HIV-positive patient with anti-CD25 treatment. Ann Rheum Dis. 2006 Dec;65(12):1677-8.

217.     Slot MC, Theunissen R, van Paassen P, Damoiseaux JG, Tervaert JW. Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study. J Autoimmune Dis 2006 May 5:3:4

218.     Belizna C, Duijvestijn A, Hamidou M, Tervaert JW. Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis. 2006 Dec;65(12):1545-50. Epub 2006 Mar 28.

219.     Cohen Tervaert JW, Paassen van P, Damoiseaux J. Type II Cryoglobulinemia is not associated with hepatitis C infection. The Dutch experience. Ann NY Acad Sci. 2007;1107:251-258. IF 1.971

220.     Cohen Tervaert JW. Vasculitis and the intensive care. Acta Clin Belg 2007;62:417-421. IF 0.583

221.     Damoiseaux JGMC, Rijkers G and Cohen Tervaert JW. Pneumococcal vaccination does not increase circulating levels of IgM antibodies to oxidized LDL in humans and therefore precludes an anti-atherogenic effect. Atherosclerosis. 2007;190:10-11. IF 3.777

222.     Damoiseaux J, Vaessen M, Knapen Y, Cservnok E, Stegeman CA, Paassen van P and Cohen Tervaert JW. Evaluation of the FIDIS Vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture’s disease. Ann N Y Acad Sci. 2007;1109:454-463. IF 1.971

223.     Drijkoningen J, Damoiseaux J, Paassen van P, Cohen Tervaert JW. Clinical manifestations of the anti-phospholipid syndrome as defined by the updated Sapporo classification criteria. Ann Rheum Dis. 2007;66:1407-1408. IF 6.956

224.     Hellmich B, Flossmann O, Gross W, Bacon P, Cohen Tervaert JW, Guillevin L, Jayne D, Mahr A, Merkel P, Raspe H, Scott D, Witter J, Yazici H and Luqmani R. EULAR Recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on ANCA-associated vasculitis. Ann Rheum Dis. 2007;66:605-617. IF 6.956

225.     Hermans MMH, Kooman JP, Meinders JM, Sande van der FM, Brandenburg V, Ketteler M, Damoiseaux JGMC, Cohen Tervaert JW, Ferreira I, Konings CJAM, Rensma PL, Gladziwa U, Kroon AA, Hoeks APG, Stehouwer CDA, Leunissen KML. Spatial inhomogeneity of common carotid artery intima media is increased in dialysis patients. Nephrol Dial Transplant. 2007;22:1205-12. IF 2.976

226.     Huugen D, Esch van A, Xiao H, Peutz-Kootstra CJ, Buurman WA, Cohen Tervaert JW, Jennette JC and Heeringa P. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int. 2007;71:646-54. IF 4.927

227.     Matthijsen RA, Huugen D, Hoebers NT, Vries B de, Peutz-Kootstra CJ, Aratani Y, Daha MR, Cohen Tervaert JW, Buurman WA, Heeringa P. Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion. Am J Pathol 2007;171:1743-52. IF 5.796

228.     Mulder DJ, Haelst P van, Wobbes M, Cohen Tervaert JW, May JF, Smit AJ, Doormaal van JJ. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. Cardiovascular Drugs and Therapy. 2007;21:91-7. IF 1.624

229.     Paassen van P, Cohen Tervaert JW, Heeringa P. Mechanisms of Vasculitis: how pauci-immune is ANCA-associated renal vasculitis? Nephron Exp Nephrol. 2007;105:e10-16. IF 1.394

230.     Paassen van P, Duijvestijn A, Debrus-Palmans L, Damoiseaux J, Vroomen M, Cohen Tervaert JW. Induction of endothelial cell apoptosis by IgG antibodies from SLE patients with nephropathy. A potential role for anti-endothelial cell antibodies. Ann NY Acad Sci. 2007;1108:147-156. IF 1.971

231.     Popa ER, Stegeman CA,  Abdulahad WH, Meer van der B, Arends J, Manson WM, Bos NA, Kallenberg CGM, Cohen Tervaert JW. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener’s granulomatosis. Rheumatology. 2007;46:1029-1033. IF 4.226

232.     Schellekens SCM, Jager CPC de, Beutler JJ, Beaumont F, Cohen Tervaert JW. Diffuse alveolar haemorrhage and respiratory insufficiency in a 31-year-old woman. Neth J Crit Care 2007;11:147-148. IF

233.     Slot M, Theunissen R, Paassen van P, Damoiseaux J, Cohen Tervaert JW. Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins. Clin Exp Immunol. 2007;149:257-264. IF 2.805

234.     Stassen P, Cohen Tervaert JW, Stegeman CA. Induction of remission in active ANCA-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide. Ann Rheum Dis. 2007;66:798-802. IF 6.956

235.     Stüve O, Marra CM, Cravens PD, Singh MP, Hu W, Lovett-Racke A, Monson NL, Phillips JT, Tervaert JW, Nash RA, Hartung HP, Kieseier BC, Racke MM, Frohman EM, Hemmer B. Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Arch Neurol. 2007;64:169-76. IF 4.9

236.     Watts R, Lane S. Hanslik T, Hauser T, Hellmich B, Koldingsnes W, Mahr A, Segelmark M, Cohen Tervaert JW, Scott D. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66:222-227. IF 6.956

237.     Leeuwen van M, Gijbels MJ, Duijvestijn A, Smook M, Gaar van de MJ, Heeringa P, Winther de MP, Cohen Tervaert JW. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice. Arterioscler Thromb Vasc Biol. 2008;28:84-9. IF 7.053

238.     Lind van Wijngaarden RA de, Rijn L de, Hagen EC, Watts RA, Gregorini G, Cohen Tervaert JW, Mahr AD, Niles JL, Heer E de, Bruijn JA, Bajema IM. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: the cause is hidden, but the result is known. Clin J Am Soc Nephrol. 2008;3:237-52. IF 4.361

239.     Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen Tervaert JW, Gross WL, Guillevin L, Jayne D, Mahr A, Merkel PA, Raspe H, Scott D, Witter J, Yazici H, Luqmani RA, on behalf of the European Vasculitis Study Group (EUVAS). Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systemic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis 2008;67:1004-10. IF 6.956

240.     Peters MJL, Halm VP van, Nurmohamed MT, Damoiseaux J, Cohen Tervaert JW, Twisk JWR, Dijkmans BAC, Voskuyl AE. Relations between autoantibodies agains oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis. J Rheumatol  2008;35(8):1495-9. IF 3.01

241.     Rouhl RPW, Van Oostenbrugge RJ, Damoiseaux J, Cohen Tervaert JW, Lodder J. Endothelial progenitor cell research in stroke. A potential shift in pathophysiological and therapeutical concepts. Stroke 2008;39(7):2156-65. IF 5.855

242.     Slot MC, Sokolowska MG, Savelkouls KG, Janssen RGJH, Damoiseaux JGMC, Cohen Tervaert JW. Immunoregulatory gene polymorphisms are associated with ANCA-related vasculitis. Clin Immunol, 2008;128(1):39-45. IF 3.217

243.     Smook MLF, van Leeuwen M, Heeringa P, Damoiseaux GMC, Theunissen R, Daemen MJAP, Lutgens E, Cohen Tervaert JW. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE-/- and APOE-/-CD40L-/- mice. Clin Exp Immunol 2008;154(2):264-9. IF 2.805

244.     Stassen PM, Cohen Tervaert JW and Stegeman CA. Comment on Ibernon et al. Clin Nephrol 2008;69:395-401. Clin Nephrology, 2008;70:270. IF 1.543

245.     Thewissen M, Cohen Tervaert JW. Leptin and ANCA-associated vasculitis: a healthy link? Rheumatology, 2008;47:387-389. IF 4.226

246.     Bakhashvilii N, Swaak AJ, Cohen Tervaert JW, Dees A. Vasculitis geassocieerd met antineutrofielencytoplasmatische antistoffen (ANCA) bij een man met ernstige vermoeidheid, koorts en een progressieve nierfunctiestoornis. Ned Tijdschr Geneeskd  2008;152:1009-14.

247.     Hendriks FAMS, Verhaegh EML, Cohen Tervaert JW. Is Pneumocystis-profylaxe met co-trimoxazol geïndiceerd bij patiënten die behandeld worden voor reumatoïde artritis? Reumatologen Vademecum, jaargang 11, nr. 1 (januari 2008)

248.     Kallenberg CGM, Cohen Tervaert. Renal manifestations. In:  Vasculitis, edited by Ball GV and Bridges SL. Oxford University Press 2008: 199-207

249.     Cohen Tervaert JW. Translational Mini-Review Series on Immunology of Vascular Disease: Accelerated atherosclerosis in vasculitis. Clin Exp Immunol 2009;156:377-385. IF 2.853

250.     Cohen Tervaert JW, Van Hoek B, Koek G. Antineutrophil Cytoplasmic Antibodies in Small-Duct Primary Sclerosing Cholangitis. Gastroenterology 2009;136:364-368. IF 12.591

251.     Cohen Tervaert JW and Damoiseaux J. Fifty years of antineutrophil cytoplasmic antibodies (ANCA) testing: do we need to revise the international consensus statement on testing and reporting on ANCA? APMIS 117 (Suppl. 127) 2009: 55-59. IF 1.316

252.     Damoiseaux J, Cohen Tervaert JW, Derksen R, Hamann D, Hooijkaas H, Klasen I, Kallenberg C, Limburg P, Smeenk R. Autoantibody standardization in The Netherlands: the past, the present, and the future. Ann N Y Acad Sci. 2009;1173:10-14. IF 2.303

253.     Damoiseaux J, Dähnrich C, Rosemann A, Probst C, Komorowski L, Stegeman CA, Egerer K, Hiepe F,  Van Paassen P, Stöcker W, Schlumberger W, Cohen Tervaert JW. A novel ELISA using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for ANCA-associated vasculitis. Ann Rheum Dis 2009;68:228-233. IF 7.188

254.     Damoiseaux J, Peeters L, Hupperts R, Boreas A, ten Cate J, Cohen Tervaert JW. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome. Ann N Y Acad Sci. 2009;1173:649-657. IF 2.303

255.     Damoiseaux J, Steller U, Buschtez M, Vaessen M, Rosemann A, Van Paassen P, Stöcker W, Fechner K, Cohen Tervaert JW.  EUROPLUSTM ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods 2009; 348:67-73. IF 2.12

256.     Flossmann O, Baslund B, Bruchfeld A, Cohen Tervaert JW, Hall C, Heinzel P, Hellmich B, Luqmani RA, Nemoto K, Tesar V, Jayne DR. Deoxyspergualin in relapsing and refractory Wegener’s granulomatosis. Ann Rheum Dis. 2009;68:1125-1130. IF 7.188

257.     Heymans S, Hirsch E, Anker SD, Aukrust P, Balligand J-L, Cohen Tervaert JW et al. Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research committee of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure 2009;11:119-129. IF 3.298

258.     Leeuwen M van, Damoiseaux J, Duijvestijn A, Cohen Tervaert JW. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis. Autoimmun Rev. 2009;9:53-57. IF 5.371

259.     Leeuwen M van, Damoiseaux J, Duijvestijn A, Heeringa P, Gijbels M, Winther M de, Cohen Tervaert JW. The IgM response to modified LDL in experimental ahterosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies. Ann N Y Acad Sci. 2009;1173:274-279. IF 2.303

260.     Lidar M, Lipschitz N, Langevitz P, Barzilai O, Ram M, Porat Katz BS, Pagnoux C, Guilpain P, Sinico RA, Radice A, Bizzaro N, Damoiseaux J, Cohen Tervaert JW, Martin J, guillevin L, Bombardieri S, Shoenfeld Y. Infectious serologies and autoantibodies in Wegener’s granulomatosis and other vasculitides: novel associations disclosed using the Rad BioPlex 2200. Ann N Y Acad Sci. 2009;1173:649-657. IF 2.303

261.     Ordonez L, Bernard I, L’Faqihi-Olive F-E, Cohen Tervaert JW, Damoiseaux J, Saoudi A. CD45RC isoform expression indentifies functionally distinct T cell subsets differentially distributed between healthy individuals and AAV patients. Plos One 2009; 4 (4); e5287

262.     Potjewijd J, Van Paassen P, Cohen Tervaert JW. Case 27-2009: A woman with fever, rash, and lymphadenopathy. N Engl J Med 2009;361(23):2294. IF 50.017

263.     Rouhl RPW, Van Oostenbrugge RJ, Damoiseaux JGMC, Debrus-Palmans LL, Theunissen ROMFIH, Knottnerus ILH, Staals JEA, Delanghe JR, Cohen Tervaert JW, Lodder J. Haptoglobin phenotype may alter endothelial progenitor cell cluster formation in cerebral small vessel disease. Curr Neurovasc Res. 2009;6:32-41. IF 3.571

264.     Smolders J, Damoiseaux J, Menheere P, Cohen Tervaert JW, Hupperts R. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol. 2009;207:117-121. IF 3.159

265.     Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009;8:621-626. IF 5.371

266.     Smolders J, Thewissen M, Peelen E, Menheere P, Cohen Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009;4:e6635.

267.     Smolders J, Damoiseaux J, Menheere P, Cohen Tervaert JW, Hupperts R. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann N Y Acad Sci. 2009;1173:515-520. IF 2.303

268.     Spaetgens B, Van Paassen P, Cohen Tervaert JW. Influenza vaccination in ANCA-associated vasculitis. Nephrol Dial Transplant 2009;24:3258. IF 3.568

269.     Stassen PM, Cohen Tervaert JW, Lems SPM, Hepkema BG, Kallenberg CGM, Stegeman CA. HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener’s granulomatosis. Rheumatology 2009;48:622-625. IF 3.282

270.     Stüve O, Cravens PD, Frohman EM, Phillips JT, Remington GM, von Geldern G, Cepok S, Singh MP, Cohen Tervaert JW, De Baets M, MacManus D, Miller DH, Radü EW, Cameron EM, Monson NL, Zhang S, Kim R, Hemmer B, Racke MK. Immunological, clinical, and radiologic status 14 months after cessation of natalizumab therapy. Neurology 2009;72:396-401. IF 7.043

271.     Wilde B, Dolff S, Cai X, Specker C, Becker J, Tötsch M, Costabel U, Dürig, Kribben A, Cohen Tervaert JW, Schmid KW, Witzke O. CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener’s granulomatosis. Nephrol Dial Transplant. 2009;24(1):171-71. IF 3.568

272.     Wilde B, van Paassen P, Damoiseaux J, Heerings-Rewinkel P, van Rie H, Witzke O, Cohen Tervaert JW. Dendritic cells in renal biopsies of patients with ANCA-associated vasculitis. Nephrol Dial Transplant. 2009;24:2151-2156. IF 3.568

273.     Belizna C, Cohen Tervaert JW, Lévesque H. Insights into the Role of Antiendotelial Cell Antibodies in Vasculitis and Connective Tissue DiseaseIn: Petrellig CT. (ed), New Research on Autoantibodies. Nova Publishers, 2009;185-198

274.     Arends SJ, Damoiseaux J, Duijvestijn A, Debrus-Palmans L, Boomars K, Broers B, Cohen Tervaert JW, Van Paassen P. Prevalence of anti-endothelial cell antibodies in idiopathic pulmonary arterial hypertension. Eur Respir J 2010;35:923-925. IF 5.545

275.     Bai L, Gabriels K, Wijnands E, Rousch EM, Daemen MJAP, Cohen Tervaert JW, Biessen EAL, Heeneman A. Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels. Thrombosis and Haemostasis 2010, 104:143-150. IF 3.803

276.     Basu N, Watts R, Bajema I, Cohen Tervaert JW, et al. EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 2010,69:1744-1750. IF 7.188

277.     Dennert RM, Paassen van P, Schalla S, Kuznetsova T, Alzand BS, Staessen JA, Velthuis S, Crijns HJ, Cohen Tervaert JW, Heymans S. Cardiac involvement in Churg-Strauss syndrome. Arth Rheum 2010;62:627-634. IF 6.787

278.     Dennert R, Velthuis S, Schalla S, Eurlings L, Suylen van RJ, Paassen van P, Cohen Tervaert JW, Wolffs P, Goossens VJ, Bruggeman C, Waltenberger J, Crijns HJ, Heymans S. Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 2010;15:193-201. IF 4.105

279.     Habets KL, Puijvelde van GHM,  Duivenvoorde van LM, Wanrooij van EJA., Vos de P, Cohen Tervaert JW, Berkel van TJC, Toes REM and Kuiper J. Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. Cardiovasc Res 2010;85:622-630. IF 5.947

280.     Jones RB, Cohen Tervaert JW, Hauser T et al. Rituximab versus cyclophosphamide in  ANCA associated renal vasculitis.  New Engl J Med 2010;363:211-220. IF 50.017

281.     Mihai C, Cohen Tervaert JW. Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010;69:319-324. IF 7.188

282.     Rouhl RPW, Oostenbrugge van RWJ, Theunissen ROMFIH, Knottnerus ILH, Staals J, Henskens LHG, Kroon AA, Leeuw de PW, Lodder J, Cohen Tervaert JW, Damoiseaux JGCM.Auto-antibodies against Oxidized LDL in Cerebral Small Vessel. Stroke 2010;41:2687-2689. IF 6.499

283.     Smolders J, Menheere P, Thewissen M, Peelen E, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Regulatory T cell function correlates with serum 25-hydroxyviramin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 2010,121:243-246. IF 2.827

284.     Smolders J, Peelen E, Thewissen M, Cohen Tervaert JW, Menheere P, Hupperts R, Damoiseaux J. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis. PLoS ONE. 2010;5:e15235. IF 4.351

285.     Wilde B, Thewissen M, Damoiseaux J, van Paassen P, Witzke O, Cohen Tervaert JW. T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells? Arthritis Res Ther 2010;12:204, epub. IF 4.485

286.     Damoiseaux J, Bakker-Jonges L, Cohen Tervaert JW, Derksen R, Hooijkaas H, Kallenberg G, Klasen I, Limburg P, Smeenk R en Hamann D. Laboratoriumdiagnostiek van ANA, anti-ds-DNA- en anti-ENA-antistoffen: aanbevelingen naar aanleiding van een enquête. Ned Tijdschr Klin Chem Labgeneesk 2010;35:234-239

287.     De Vries M, Drent M, Cohen Tervaert JW. Vasculitis induced by drugs. In: “Drug-induced and iatrogenic respiratory disease”. P. Camus and E.C. Rosenow III, Ed., Edward Arnold (Publishers) Ltd., 2010: 308-317. ISBN-13 978-0-340-80973-0

288.     Thewissen MM, Damoiseaux JG, Duijvestijn AM, van Greevenbroek MM, van der Kallen CJ, Feskens EJ, Blaak EE, Schalkwijk CG, Stehouwer CD, Tervaert JW, Ferreira I. Abdominal fat mass is associated with immune activation: the CODAM study. Obesity; 2011;19:1690-1698

289.     Wilde B, van Paassen P, Witzke O, Cohen Tervaert JW. New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 2011;79:599-612. IF 6.418

290.     Cohen Tervaert JW. Hypertension: an autoimmune disease? Hypertens Res 2011; 34:443-444. IF 3.146

291.     Hilhorst M, van Paassen P, van Breda Vriesman P, Cohen Tervaert JW. Immune complexes in acute adult-onset Henoch-Schönlein nephritis. Nephrol Dial Transpl; 2011; 12:3960-3967. 1-8. IF 3.568

 

292.     Smolders J. Thewissen M., Theunissen R, Peelen E, Knippenberg S, Menheere P, Cohen Tervaert J.W, Hupperts R, Damoiseaux J. Vitamin D-Related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis. J Neuroimmunol 2011; 235:91-97.

293.     Cohen Tervaert JW, Stegeman CA. Behandeling van patiënten met het Churg Strauss syndroom, dan wel ANCA geassocieerde vasculitis. Ned Tijdschr Geneeskd 2011;155(6):A3140

294.     Peelen E, Knippenberg S, Muris A-H, thewissen M, Smolders J, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun Rev 2011; 12:733-43. IF 6.368

295.     Knippenberg S, Smolders J, Thewissen M, Peelen E, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Effect of vitamin D3 supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis. Mult. Scler. 2011; 17: 1418-1423.

296.     Lidar M, Lipschitz N, Agmon-Levin N, Langevitz P, Barzilai O, Ram M, Porat-Katz BS, Bizzaro N, Damoiseaux J, Tervaert JW, Devita S, Bombardieri S, Schoenfeld Y. Infectious Serologies and Autoantibodies in Hepatitis C and autoimmune Disease-Associated Mixed Cryoglobulinemia. Clin Rev Allery Immunol 2012; 42:238-246

297.     Rouhl RP, Damoiseaux JG, Lodder J, Theunissen RO, Knottnerus IL, Staals J, Henskens LH, Kroon AA, de Leeuw PW, Tervaert JW, van Oostenbrugge RJ. Vascular inflammation in cerebral small vessel disease. Neurobiol Aging 2011 May 19 Epub

298.     Thewissen M, Damoiseaux J, van de Gaar J, Cohen Tervaert JW. Neutrophils and T cells: Bidirectional effects and functional interferences. Mol Immunol 2011: 48:2094– 2101

299.     Durme van CMPG, Kisters JMH, van Paassen P, van Etten RW, Cohen Tervaert JW. Multiple endocrine abnormalities as first presentation of granulomatosis with polyangitis (Wegener’s granulomatosis). Lancet 2011;378 (9790):540

300.     Cohen Tervaert JW. Rituximab in ANCA-associated vasculitis: a revolution? Nephrol Dial Transplant 2011;10:3077-3079

301.     Jong de HJI, Klungel OH, Dijk van L, Vandebriel RJ, Leufkens HGM, Laan van der JW, Cohen Tervaert JW, Loveren van H. Use of statins is associated with an increased risk of Rheumatoid Arthritis. Ann Rheum Dis 2012; 71:648-654

302.     Rouhl RPW, Mertens AECS, Oostenbrugge van RJ, Damoiseaux JGMC, Debrus-Palmans LL, Henskens LHG, Kroon AA, Leeuw, PW de, Lodder J, Cohen Tervaert JW. Angiogenic T-cells and putative endothelial progenitor cells in Hypertension related cerebral small vessel disease. Sroke 2012: 43:256-258

303.     Cohen Tervaert JW. Ziekte van Wegener: systeemvasculitis. ILD Care Today; 2011;4(1):16-21

304.     de Jong HJI, Cohen Tervaert JW, Saldi SRF, Vandebriel RJ, Souverein PC, Meyboom RHB, van Loveren H, Klungel OH. Association Between Statin Use and Lupus-Like Syndrome Using Spontaneous Reports. Semin Arthritis Rheum. 2011 41:373-381

305.     Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere p, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naïve/memory Breg ratio during a relapse but not in remission. J Neuroimmunol; 2011; 239:80-86

306.     Peelen E, Damoiseaux J, Smolders J. Knippenberg S, Menheere P, Cohen Tervaert JW, Hupperts R, Thewissen M. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. Journal of Neuroimmun. 2011; 240-241:97-103.

307.     Damoiseaux J, Austen J, Cohen Tervaert JW. ANCA Diagnostics in Clinical Practice. In: New Developments. Advances in the diagnosis and treatment of vasculitis. LM Amezcua-Guerra (ed). ISBN 978-953-307-786-4. 2011:1-18

308.     Rocha M, et al. Genetic polymorphisms and surface expression of CTLA-4 and PD-1 on T-cells of silica-exposed workers. Int J Hyg Environ Health 2012

309.     Goossens GH et al. Expression of NLPR3 inflammasome and T cell population markers in adipose tissue are associated with insulin resistance and impaired glucose metabolism in humans. Mol Immunol 2012; 50:142-149

310.     Muris AH, et al. Intracellular IL-10 detection in T cells by flowcytometry: the use of protein transport inhibitors revisited. J Immunol Methods 2012

311.     Damoiseaux J, et al. Autoantibody detection in bullous pemphigoid: Clinical Evaluation of the EUROPLUS Dermatology Mosaic. J Immunol Methods 2012

312.     Vandebriel R, et al. Statins accelerate the onset of collagen type II-induced arthritis in mice. Arthritis Res Ther 2012; 14:R90

313.     Wilde B, et al. Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis. Rheumatology (Oxford) 2012

314.     Kappel R et al. Een alternatief voor silicone. Medisch Contact 2012: 980-982.

315.     Lyons PA, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367:214-23

316.     Rutgers A et al. Autoantibodies and vascular inflammation. In: Hoffman G, Weyand CM, Langford CA, Gorozny JJ (eds). Inflammatory diseases of blood vessels. Wiley &sons. 2012. ISBN-13:978-1-4443-3822-5

317.     Cohen Tervaert JW. Cholesterol and modifications of cholesterol in rheumatic diseases. In: Hoffman G, Weyand CM, Langford CA, Gorozny JJ (eds). Inflammatory diseases of blood vessels. Wiley &sons. 2012. ISBN-13:978-1-4443-3822-5

318.     Cohen Tervaert JW, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification, and follow-up ? Clin Rev Allergy Immunol 2012

319.     Altman A, Szyper-Kravitz M, Agmon-Levin N, Gilburd B, Anaja JM, Barzilai O, Ram M, Bizzaro N, Stojanovich L, Damoiseaux J, Tervaert JW, Bombardieri S, Amital H, Shamis A, Shoenfeld Y. Prevalence of rubella serum antibody in autoimmune diseases.Rev Bras Reumatol. 2012;52:307-18.

320.     Hilhorst M, Wilde B, van Paassen P, Winkens B, van Breda Vriesman P, Cohen Tervaert JW; for the Limburg Renal Registry. Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study.Nephrol Dial Transplant. 2013 Feb;28(2):373-9.

321.     Damoiseaux J, Mallet K, Vaessen M, Austen J, Cohen Tervaert JW. Automatic Reading of ANCA-Slides: Evaluation of the AKLIDES System.Clin Dev Immunol. 2012;2012:762874.

322.     Petermann Smits DR, Wilde B, Kianersi Adegani M, de Jongh H, van Paassen P, Cohen Tervaert JW. Metabolic syndrome in ANCA-associated vasculitis.Rheumatology (Oxford). 2013 Jan;52(1):197-203.

323.     Wilde B, Thewissen M, Damoiseaux J, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy.Arthritis Res Ther. 2012;14(5):R227.

324.     Willems CH, Zimmermann LJ, Sanders PJ, Wagendorp M, Kloosterboer N, Cohen Tervaert JW, Duimel HJ, Verheyen FK, van Iwaarden JF. Alveolocapillary model system to study alveolar re-epithelialization.Exp Cell Res. 2013; 319:64-74.

325.     Peelen E, Rijkers G, Meerveld-Eggink A, Meijvis S, Vogt M, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Relatively high serum vitamin D levels do not impair the antibody response to encapsulated bacteria.Eur J Clin Microbiol Infect Dis. 2013; 32:61-69.

326.     de Jong HJ, Saldi SR, Klungel OH, Vandebriel RJ, Souverein PC, Meyboom RH, Passier JL, van Loveren H, Cohen Tervaert JW. Statin-associated polymyalgia rheumatica. An analysis using WHO global individual case safety database: a case/non-case approach.PLoS One. 2012;7(7):e41289.

327.     Dennert R, van Paassen P, Wolffs P, Bruggeman C, Velthuis S, Felix S, van Suylen RJ, Crijns HJ, Cohen Tervaert JW, Heymans S. Differences in virus prevalence and load in the hearts of patients with idiopathic dilated cardiomyopathy with and without immune-mediated inflammatory diseases.Clin Vaccine Immunol. 2012; 19:1182-7

328.     Čučnik S, Kveder T, Artenjak A, Ulcova Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Alessandri C, Valesini G, Avčin T, Cohen Tervaert JW, Rozman B, Božič B. Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.Lupus. 2012;21:764-5

329.     de Jong HJ, Vandebriel RJ, Saldi SR, van Dijk L, van Loveren H, Cohen Tervaert JW, Klungel OH. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and the risk of developing rheumatoid arthritis in antihypertensive drug users.Pharmacoepidemiol Drug Saf. 2012;21:835-43.

330.     Vandebriel RJ, De Jong HJ, Gremmer ER, Klungel OH, Tervaert JW, Slob W, Van Der Laan JW, Van Loveren H. Response to 'Statins accelerate the onset of collagen type II-induced arthritis in mice'-authors' reply. Arthritis Res Ther. 2013 Mar 8;15(2):403.

331.     van Leeuwen M, Kemna MJ, de Winther MP, Boon L, Duijvestijn AM, Henatsch D, Bos NA, Gijbels MJ, Tervaert JW.Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice. PLoS One. 2013 Jul 16;8(7):e68039. doi: 10.1371/journal.pone.0068039. Print 2013.

332.     Arends SJ, Damoiseaux JG, Duijvestijn AM, Debrus-Palmans L, Vroomen M, Boomars KA, Rocca HP, Reutelingsperger CP, Tervaert JW, van Paassen P IgG anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension?. Clin Exp Immunol. 2013 Dec;174(3):433-40. doi: 10.1111/cei.12166.

333.     Chand S, Holle JU, Hilhorst M, Simmonds MJ, Smith S, Kamesh L, Hewins P, McKnight AJ, Maxwell AP, Cohen Tervaert JW, Wieczorek S, Harper L, Borrows R. Caveolin-1 single nucleotide polymorphism in antineutrophil cytoplasmic antibody associated vasculitis. PLoS One. 2013 Jul 19;8(7):e69022. doi: 10.1371/journal.pone.0069022.

334.     Cohen Tervaert JW, Kappel RM. Silicone implant incompatibility syndrome (SIIS): A frequent cause of ASIA (Shoenfeld's syndrome).Immunol Res. 2013; 56; 293-298.

335.     Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC. Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev. 2013; 12:1004-1015. doi 10.1016/j.autrev.2013.03.013.

336.     Cohen Tervaert JW. What to do when you suspect your patient suffers from pulmonary vasculitis? Expert Opin Med Diagn. 2013 Jan;7(1):1-4

337.     Husmann CA, Holle JU, Moosig F, Mueller S, Wilde B, Cohen Tervaert JW, Harper L, Assmann G, Gross WL, Epplen JT, Wieczorek S. Genetics of toll like receptor 9 in ANCA associated vasculitides Ann Rheum Dis. 2013 Apr 16. [Epub ahead of print]

338.     Cohen Tervaert JW. Cardiovascular disease due to accelerated atherosclerosis in systemic vasculitides.Best Pract Res Clin Rheumatol. 2013 Feb;27(1):33-44.

339.     Rasmussen N, Salmela A, Ekstrand A, de Groot K, Gregorini G, Cohen Tervaert JW, Gross WL, Wiik A, Jayne DR, On Behalf Of The European Vasculitis Study Group Euvas 1. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity. Clin Exp Rheumatol. 2013 2013 Jan-Feb;31(1 Suppl 75):S38-44.

340.     Peelen E, Thewissen M, Knippenberg S, Smolders J, Muris AH, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. Fraction of IL-10(+) and IL-17(+) CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.J Neuroimmunol. 2013 May 15;258(1-2):77-84.

341.     Heijnen BF, Nelissen J, van Essen H, Fazzi GE, Cohen Tervaert JW, Peutz-Kootstra CJ, Mullins JJ, Schalkwijk CG, Janssen BJ, Struijker-Boudier HA. Irreversible renal damage after transient renin-angiotensin system stimulation: involvement of an AT1-receptor mediated immune response.PLoS One. 2013;8(2):e57815.

342.     Cohen Tervaert JW. Membranoproliferative glomerulonephritis: the times they are a-changin’. Clin Exp Nephrol. 2013 Aug 28. [Epub ahead of print]

343.     Timmermans SAMEG, Ayalon R, van Paassen P, Beck Jr, LH, van Rie H, Wirtz JJJM, Verseput GH, Frenken LH, Salant DJ, Cohen Tervaert JW, on behalf of the Limburg Renal Registry. Anti–Phospholipase A2 Receptor Antibodies and Malignancy in Membranous Nephropathy. Am J Kidney Dis 2013 Dec;62(6):1223-5. doi: 10.1053/j.ajkd.2013.07.019.

344.     Hilhorst M, Wilde B, van Breda Vriesman P, van Paassen P, Cohen Tervaert JW; Limburg Renal Registry. Estimating Renal Survival Using the ANCA-Associated GN Classification. J Am Soc Nephrol. 2013 Sep;24(9):1371-5. doi: 10.1681/ASN.2012090912.

345.     Bech AP, Reichert LJ, Cohen Tervaert JW Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein). Neth J Med. 2013 May;71(4):220-1.

346.     Wilde B, Thewissen M, Damoiseaux J, Knippenberg S, Hilhorst M, van Paassen P, Witzke O, Cohen Tervaert JW. Regulatory B cells in ANCA-associated vasculitis. Ann Rheum Dis. 2013 Aug;72(8):1416-9. doi: 10.1136/annrheumdis-2012-202986.

347.     Kallenberg CGM, Cohen Tervaert JW. Vasculitis. In: Bijlsma JWJ, van Laar JM. Leerboek reumatologie en klinische immunologie. Bohn, Stafleu, van Loghum. 2013; pp 133-144.

348.     de Leeuw K, Rutgers A, Cohen Tervaert JW. Immuuntherapie bij cryoglobuline-geassocieerde vasculitis. In: van de Loosdrecht AA, Kallenberg CGM. Immuuntherapie in de Interne Geneeskunde. Van Zuiden; 2013; pp. 165-171.

349.     Cohen tervaert JW, van Paassen P, Kallenberg CGM, Stegeman CA. Biologicals voor vasculitis. In: van de Loosdrecht AA, Kallenberg CGM. Immuuntherapie in de Interne Geneeskunde. Van Zuiden; 2013; pp. 147-164.

350.     Geerlings CJ, Man Pd, Rietveld AP, Touw DJ, Cohen Tervaert JW. A practical thrice weekly Ertapenem dosage regime for chronic hemodialysis patients? Clin Nephrol. 2013 Oct;80(10):312

351.     Damoiseaux J, Cohen Tervaert JW. Diagnostics and Treatment of Cryoglobulinaemia: It Takes Two to Tango Clin Rev Allergy Immunol. 2013 Sep 26. [Epub ahead of print] 109.

352.     Wilde B, Dolff S, Damoiseaux J, Witzke O, Tervaert CJ. Dysregulation of regulatory T-cells in ANCA-associated vasculitis Arthritis Rheum. 2013 Dec;65(12):3316. doi: 10.1002/art.38212.

353.     Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M, Bossuyt X, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2013 Oct 14. doi: 10.1136/annrheumdis-2013-203863. [Epub ahead of print]

354.     De Jong HJ, Damoiseaux JG, Vandebriel RJ, Souverein PC, Gremmer ER, et al. Statin Use and Markers of Immunity in the Doetinchem Cohort Study. PLOS One 2013; 8:e77587

355.     Hilhorst M, Winckers K, Wilde B, van Oerle R, Ten Cate H, Cohen Tervaert JW. Patients with Antineutrophil Cytoplasmic Antibodies Associated Vasculitis in Remission Are Hypercoagulable. J Rheumatol. 2013 Dec;40(12):2042-6. doi: 10.3899/jrheum.130200

356.     Kemna MJ, Tervaert JW. Does one size fit all? J Rheumatol. 2013 Nov;40(11):1781-4. doi: 10.3899/jrheum.130805.

357.     Hilhorst M, Theunissen R, van Rie H, van Paassen P, Tervaert JW. DNA extraction from long-term stored urine. BMC Nephrol. 2013 Oct 30;14:238. doi: 10.1186/1471-2369-14-238.

358.     Rocha-Parise M, Santos LM, Damoiseaux JG, Bagatin E, Lido AV, Torello CO, Cohen Tervaert JW, Queiroz ML. Lymphocyte activation in silica-exposed workers. Int J Hyg Environ Health, 2014. 217(4-5): p. 586-91.doi: 10.1016/j.ijheh.2013.11.002

359.     Wieczorek S, Holle JU, Cohen Tervaert JW, Harper L, Moosig F, Gross WL, Epplen JT. The SEM6A6 Locus Is Not Associated With Granulomatosis With Polyangiitis or Other Forms of Antineutrophil Cytoplasmic Antibody-Associated Vasculitides in Europeans: Comment on the Article by Xie et al.Arthritis Rheumatol. 2014 May;66(5):1400-1. doi: 10.1002/art.38367.

360.     Kappel RM, Cohen Tervaert JW, Pruijn GJ. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) due to silicone implant incompatibility syndrome in three sisters. Clin Exp Rheumatol. 2014 Mar-Apr;32(2):256-8.

361.     Timmermans SA, Damoiseaux JG, Heerings-Rewinkel PT, Ayalon R, Beck LH Jr, Schlumberger W, Salant DJ, van Paassen P, Tervaert JW; Limburg Renal Registry. Evaluation of Anti-PLA2R1 as Measured by a Novel ELISA in Patients With Idiopathic Membranous Nephropathy: A Cohort Study. Am J Clin Pathol. 2014 Jul;142(1):29-34.

362.     Wilde B, Witzke O, Cohen Tervaert JW. Rituximab and B-Cell Return in ANCA-Associated Vasculitis. Am J Kidney Dis. 2014 Jun;63(6):1066.

363.     Kemna MJ, Damoiseaux J, Austen J, Winkens B, Peters J, van Paassen P, Cohen Tervaert JW. ANCA as a Predictor of Relapse: Useful in Patients with Renal Involvement But Not in Patients with Nonrenal Disease. J Am Soc Nephrol. 2015 Mar;26(3):537-42. doi: 10.1681/ASN.2013111233.

364.     de Jong HJ, Meyboom RH, Helle MJ, Klungel OH, Niskanen L, Cohen Tervaert JW. Giant cell arteritis and polymyalgia rheumatica after reexposure to a statin: a case report. Ann Intern Med. 2014 Oct 21;161(8):614-5. doi: 10.7326/L14-5020-6.

365.     Cohen Tervaert JW, Kallenberg CG. Clinical immunology - Autoimmunity in the Netherlands. Immunol Lett. 2014 Dec;162(2PB):134-140. doi: 10.1016/j.imlet.2014.10.008

366.     Walsh M, Faurschou M, Berden A, Flossmann O, Bajema I, Hoglund P, Smith R, Szpirt W, Westman K, Pusey CD, Jayne DR, Abramowicz D, Wissing M, Blockmans D, Madhoun P, Sennesael J, Stolear J, Tesar V, Chabova V, Rychlik I, Rasmussen N, Ekstrand A, Grönhagen C, Lesavre P, Vanhille P, Feighery C, de Groot K, Andrassy K, Hergesell O, van der Woude F, Nowack R, Gross W, Schmitt W, Schneider M, Specker C, Rupprecht H, Weber P, Weidner S, Gregorini G, Sinico A, Dadonieme J, Kallenberg C, Stegeman C, Hagen C, van Gurp E, Siegert C, Verburgh C, Cohen Tervaert JW, Mirapeix E, Serra A, Valles M, Poveda R, Ballarin J, Pettersson E, Bruchfeld A, Germanis G, Selga D, Heigl Z, Lundberg I, Svenungssen E, Gaskin G, Mathieson P, Watts R, Feehally J, Burns A, Luqmani R, Bacon P, Adu D, Savage C. Long-term follow-up of cyclophosphamide compared with azathioprine for initial maintenance therapy in ANCA-associated vasculitis. Clin J Am Soc Nephrol, 2014 Sep 5; 9 (9) :1571-6.

367.     Timmermans SA, van Paassen P, Cohen Tervaert JW. Recent advances in the understanding of immune-mediated nephrotic syndrome: diagnostic and prognostic implications. Expert Rev Clin Immunol. 2015 Mar 10:1-12.

368.     Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J, Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Čučnik S. Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of β2-glycoprotein I. Immunol Res. 2015 Feb;61(1-2):35-44.

369.     Peelen E, Muris AH, Damoiseaux J, Knippenberg S, Broens K, Smolders J, Cohen Tervaert JW, Hupperts R, Thewissen M. GM-CSF production by CD4(+) T cells in MS patients: Regulation by regulatory T cells and vitamin D. J Neuroimmunol. 2015 Mar 15;280:36-42. doi: 10.1016/j.jneuroim.2015.02.007.

370.     Jones RB, Furuta S, Cohen Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh M, Westman K, Jayne DR; for the European Vasculitis Society (EUVAS). Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial. Ann Rheum Dis. 2015 Jun;74(6):1178-82.

371. Kemna MJ, Bucerius J, Drent M, Vöö S, Veenman M, van Paassen P, Tervaert JW, van Kroonenburgh MJ. Aortic (18)F-FDG uptake in patients suffering from granulomatosis with polyangiitis.Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1423-9.

372.  van der Veer T, Pennings E, Tervaert JW, Korswagen LA. Levamisole-contaminated cocaine: a hairy affair. BMJ Case Rep. 2015 Aug 26;2015.

373. Wilde B, Slot M, van Paassen P, Theunissen R, Kemna M, Witzke O, Cohen Tervaert JW. Phosphorylcholine antibodies are diminished in ANCA-associated vasculitis. Eur J Clin Invest. 2015 Jul;45(7):686-91

374. Hilhorst M, Kok HM, Broekhuizen R, van Paassen P, van Breda Vriesman P, Goldschmeding R, Nguyen TQ, Cohen Tervaert JW; Limburg Renal Registry. Connective tissue growth factor and the cicatrization of cellular crescents in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2015 Aug;30(8):1291-9.

375. Hollan I, Dessein PH, Ronda N, Wasko MC, Svenungsson E, Agewall S, Cohen-Tervaert JW, Maki-Petaja K, Grundtvig M, Karpouzas GA, Meroni PL. Prevention of cardiovascular disease in rheumatoid arthritis. Autoimmun Rev. 2015 Oct;14(10):952-69

376. Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, Merken J, Kuznetsova T, Staessen JA, Brunner-La Rocca HP, van Paassen P, Cohen Tervaert JW, Heymans S. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: Eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015 Jul 15;199:170-179

377. Hilhorst M, van Paassen P, van Rie H, Bijnens N, Heerings-Rewinkel P, van Breda Vriesman P, Cohen Tervaert JW; Limburg Renal Registry. Complement in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2015 Aug 13. pii: gfv288. [Epub ahead of print]

378. Kemna MJ, Vandergheynst F, Vöö S, Blocklet D, Nguyen T, Timmermans SA, van Paassen P, Cogan E, van Kroonenburgh MJ, Tervaert JW. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine (Baltimore). 2015 May;94(20):e747

379. Artenjak, A., Locatelli, I., Brelih, H., Simonic, D.M., Ulcova-Gallova, Z., Swadzba, J., Musial, J., Iwaniec, T., Stojanovich, L., Conti, F., Valesini, G., Avcin, T., Cohen Tervaert, J.W., Shoenfeld, Y., Blank, M., Ambrozic, A., Sodin-Semrl, S., Bozic, B., and Cucnik, S., Erratum to: Immunoreactivity and avidity of IgG anti-beta2-glycoprotein I antibodies from patients with autoimmune diseases to different peptide clusters of beta2-glycoprotein I. Immunol Res, 2015. 61(1-2): p. 45.

380. Hilhorst M, van Paassen P, Tervaert JW; Limburg Renal Registry. Proteinase 3-ANCA Vasculitis versus Myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol. 2015 2015 Oct;26(10):2314-27.

381. Jacobs, J., Voskuyl, A.E., Korswagen, L.A., Theunissen, R., Cohen Tervaert, J.W., and Bultink, I.E., The association between FOK-I vitamin D receptor gene polymorphisms and bone mineral density in patients with systemic lupus erythematosus. Clin Exp Rheumatol, 2015. 33(5): p. 765

382. Timmermans, S.A., Abdul Hamid, M.A., Cohen Tervaert, J.W., Damoiseaux, J.G., van Paassen, P., and Limburg Renal, R., Anti-PLA2R Antibodies as a Prognostic Factor in PLA2R-Related Membranous Nephropathy. Am J Nephrol, 2015. 42(1): p. 70-7.

383. Cohen Tervaert JW. The Renaissance of Antineutrophil Cytoplasmic Antibodies as a Predictor of Relapse: Ippon for Japan. J Rheumatol. 2015 Oct;42(10):1734-6.

384. Schulkes KJ, Cohen Tervaert JW, Rijken F, Haas LE. Dapsone hypersensitivity syndrome not related to G6PD deficiency. BMJ Case Rep. 2015 Dec 18;2015. pii: bcr2015212742.

385. Jeffs LS, Nitschke J, Cohen Tervaert JW, Peh CA, Hurtado PR. Viral RNA in the influenza vaccine may have contributed to the development of ANCA-associated vasculitis in a patient following immunisation. Clin Rheumatol. 2015 Sep 12. [Epub ahead of print]

386. Koh JH, Kemna MJ, Tervaert JW, Kim WU. Can a rise in ANCA Titer Predict Relapses in ANCA-Associated Vasculitis? Arthritis Rheumatol. 2016 Feb 16. doi: 10.1002/art.39639. [Epub ahead of print]

387. Hilhorst M, Arndt F, Kemna MJ, Wieczorek S, Donner Y, Wilde B, Epplen JT, van Paassen P, Cohen Tervaert JW. HLA-DPB1 as a risk factor for relapse in ANCA-associated vasculitis - a cohort study. Arthritis Rheumatol. 2016 Feb 11. doi: 10.1002/art.39620. [Epub ahead of print

388. Csernok E, Damoiseaux J, Rasmussen N, Hellmich B, van Paassen P, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X. Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Autoimmun Rev. 2016 Mar 9. pii: S1568-9972(16)30058-1. doi: 10.1016/j.autrev.2016.03.010. [Epub ahead of print]

389. Kemna MJ, Schlumberger W, van Paassen P, Dähnrich C, Damoiseaux JG, Cohen Tervaert JW. The avidity of PR3-ANCA in patients with granulomatosis with polyangiitis during follow-up. Clin Exp Immunol. 2016 Mar 24. doi: 10.1111/cei.12796. [Epub ahead of print]

390. Sanders JS, de Joode AA, DeSevaux RG, Broekroelofs J, Voskuyl AE, van Paassen P, Kallenberg CG, Tervaert JW, Stegeman CA. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. Nephrol Dial Transplant. 2016 May 30. pii: gfw211. [Epub ahead of print]

391. de Vries MA, Klop B, van der Meulen N, van de Geijn GM, Prinzen L, van der Zwan E, Birnie E, Cohen Tervaert JW, Liem AH, de Herder WW, Castro Cabezas M. Leucocyte-bound apolipoprotein B in the circulation is inversely associated with the presence of clinical and subclinical atherosclerosis. Eur J Clin Invest. 2016 Jun 17. doi: 10.1111/eci.12650

392. Wilde B, Mertens A, Arends SJ, Rouhl RP, Bijleveld R, Huitema J, Timmermans SA, Damoiseaux J, Witzke O, Duijvestijn AM, van Paassen P, van Oostenbrugge RJ, Cohen Tervaert JW. Endothelial progenitor cells are differentially impaired in ANCA-associated vasculitis compared to healthy controls. Arthritis Res Ther. 2016 Jun 23;18:147. doi: 10.1186/s13075-016-1044-8.

393. Colaris MJ, de Boer M, van der Hulst RR, Cohen Tervaert JW. Two hundreds cases of ASIA syndrome following silicone implants: a comparative study of 30 years and a review of current literature. Immunol Res. 2016 Jul 13. [Epub ahead of print]

394. de Boer M, Colaris M, van der Hulst RR, Cohen Tervaert JW. Is explantation of silicone breast implants useful in patients with complaints? Immunol Res. 2016 Jul 13. [Epub ahead of print]

395. David PR, Dagan A, Colaris M, de Boer M, Cohen Tervaert JW, Shoenfeld Y. Churg-Strauss Syndrome: Singulair or Silicone (or both ?). Isr Med Assoc J. 2016 Mar-Apr;18(3-4):168-70.

396. Damoiseaux, J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, Vermeersch P, Blockmans D, Cohen Tervaert JW, Bossuyt X. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis 2016 [Epub ahead of print].